Claritas Axis provides drug supply chain compliance audits specifically designed for independent med spas and physician practices administering RX drugs including Botox, fillers, GLP-1s, IV therapy, hormone replacement therapy, and biologics. Claritas Axis identifies every documentation gap your practice carries under the Drug Supply Chain Security Act, confirms whether your vendors are FDA-authorized trading partners, and delivers a written remediation roadmap your team can implement immediately. The Drug Supply Chain Security Act has been federal law since 2013. Most med spa owners have never heard of it. That phase is over. In January 2026 alone, over 200 med spas were inspected. 87 failed. Licenses were suspended. Licenses were revoked. That was one state. One month. Regulators have confirmed the program is expanding. The FDA has full visibility into the commercial drug supply chain from manufacturer to patient. That visibility includes your distributors. That visibility includes your practice. If your team cannot document where your drugs came from, who sold them, and what happened to every unit, that gap exists whether you know about it or not. An audit completed on your terms is always less disruptive than an inspection completed on theirs. Come find Claritas Axis at the show. No pressure, no pitch. Just straight answers on where your practice stands.